FDA approves Moderna's updated 2026-2027 COVID-19 vaccines

August 27, 2026 3:58 PM

Moderna, Inc. (NASDAQ: MRNA) announced that the U.S. Food and Drug Administration has approved updated 2026-2027 formulations of two COVID-19 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found